MGEE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently.", "Not a good buy right now for an impatient entry: price ($80.67) is pressing near immediate resistance (R1 ~80.68) with limited near-term upside before the next resistance (R2 ~81.40).", "Wall Street stance is net bearish at current levels: Morgan Stanley is Underweight with a $73 target (below the current price), implying downside vs. target.", "Near-term statistical pattern read is slightly negative (next day/week expected modest drift lower), even though the 1-month pattern bias is positive."]
["Trend/Momentum: MACD histogram is positive and expanding (bullish momentum improving).", "RSI(6) ~64: mild-bullish/near-overbought region but not extreme; suggests upside may be getting less favorable vs. risk at this level.", "Moving averages: converging MAs suggest consolidation/indecision rather than a strong trend continuation setup.", "Key levels: Pivot 79.51; Support S1 78.34 (then S2 77.62). Resistance R1 80.68 (current price is essentially at this level) then R2 81.40.", "Candlestick-pattern analogs: ~70% chance of -0.28% next day and -0.38% next week; but +4.52% bias over the next month (good longer swing, weaker immediate entry)."]
["Fundamentals are steady: 2025/Q3 revenue +4.27% YoY, net income +8.69% YoY, EPS +7.96% YoY (supports a stable utility uptrend longer-term).", "Low-IV regime (by percentile/rank) can help if a bullish catalyst emerges (upside optionality is cheaper than usual).", "No negative news flow in the last week (no fresh headline overhang)."]
lowered the target again\u2014bearish vs. current $80.67.", "Technically extended into resistance (R
with limited immediate reward-to-risk for an impatient entry.", "Options positioning is slightly put-heavy (OI PCR 1.
and there\u2019s no confirming bullish volume."]
["Latest quarter provided: 2025/Q3.", "Revenue: $175.679M, +4.27% YoY (moderate growth).", "Net income: $44.497M, +8.69% YoY (profit growth outpacing revenue).", "EPS: $1.22, +7.96% YoY (steady earnings expansion).", "Gross margin: 65.76%, -0.51% YoY (slight margin compression, not severe but worth noting).", "Ownership/trading context: Hedge funds neutral (no notable quarterly trend); insiders neutral (no notable last-month trend).", "Congress trading: no recent congress trading data available in the last 90 days."]
["Recent trend (Morgan Stanley only): consistently Underweight; price target has moved 75 -> 71 (2025-12-16), then 74 (2026-01-21), then 73 (2026-02-02).", "Net takeaway: targets remain well below the current price, implying Wall Street (as reflected here) sees the stock as overvalued/limited upside at current levels.", "Pros view: regulated utility stability and earnings consistency (supports holding/longer-term).", "Cons view: limited upside vs. target and valuation skepticism at current price (argues against buying now)."]
